Gérard Michel
Prof Gérard Michel is an expert in Hematology at Hôpital de la Timone (France). As of October 2026, ScienceLeadR ranks Gérard Michel in the top 1% of experts worldwide for Leukemia. Gérard Michel has authored 348 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 1 of them ongoing. SLR score: 1,015 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties: Transplantation - Oncology - Pediatrics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1996 - 2026
Number : 348
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Pregnancy outcomes in women conceiving after hematopoietic stem cell transplantation versus conventional chemotherapy for childhood or adolescent acute leukemia. PMID 42675121 — cells, pregnancy, parturition, microscopy, electron, scanning transmission, hematopoietic stem cell transplantation, pregnancy outcome, bone marrow transplantation, alkylating agents, leukemia, stem cells, drug therapy, adolescent, cell transplantation, conditioning, psychological, stem cell transplantation, hematopoietic stem cells, transplantation, chemotherapy | Bone Marrow Transplant | 2026 | 0 |
| Long-term complications after total body irradiation in children younger than 4 years transplanted for acute lymphoblastic leukemia. PMID 42624967 — precursor cell lymphoblastic leukemia-lymphoma, whole-body irradiation, leukemia, child | Bone Marrow Transplant | 2026 | 1 |
| Evaluation of oral health and oral health-related quality of life among childhood leukemia survivors: a pilot study in the LEA cohort. PMID 42161079 — pilot projects, oral health, quality of life, pilots, precursor cell lymphoblastic leukemia-lymphoma, leukemia, diagnosis, therapeutics, pediatrics, history | Arch Pediatr | 2026 | 0 |
| Increased susceptibility to long-term complications in leukemia survivors who received hematopoietic stem cell transplantation during adolescence. PMID 42086171 — cells, microscopy, electron, scanning transmission, hematopoietic stem cell transplantation, multiple chronic conditions, leukemia, stem cells, adolescent, morbidity, cell transplantation, stem cell transplantation, hematopoietic stem cells, transplantation, child | Transplant Cell Ther | 2026 | 0 |
| Chronic graft-versus-host disease in long-term survivors of childhood leukemia. PMID 41560847 — microscopy, electron, scanning transmission, leukemia, graft vs host disease, transplants, therapeutics, bronchiolitis obliterans syndrome | Hemasphere | 2026 | 0 |
Clinical Studies 13
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 4
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Combination of an Anti PD1 Antibody With Tisagenlecleucel Reinfusion in Children Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence NCT05310591 — cells, research design, precursor cell lymphoblastic leukemia-lymphoma, safety, lymphoma, cyclophosphamide, leukemia, drug therapy, leukemia, lymphoid, adolescent, nivolumab, therapeutics, b-lymphocytes, child, chemotherapy, car-t cell | Phase 1/Phase 2 | Recruiting | 2023 |
LeadR Networks
Main global connection map